Intellectual Property
Jan. 26, 2018
Jury awards Illumina $26.7M from rival in patent infringement trial
A federal jury found that molecular diagnostics company Ariosa Diagnostics Inc. infringed two Illumina Inc. patents on a prenatal genetic defects test and owes $26.7 million.
SAN FRANCISCO -- A federal jury found Thursday that molecular analysis company Ariosa Diagnostics Inc. infringed two Illumina Inc. patents on a prenatal genetic defects test and owes $26.7 million.
All of Ariosa's counterclaims were rejected.
The damages award is less than the $104 million Illumina sought in the trial. The San Diego-based Illumina may file a motion for an injunction blocking the Sa...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In